College News

Results from a Phase 3 clinical trial offer new hope for patients with advanced pancreatic cancer, showing the experimental drug daraxonrasib significantly extended survival compared with chemotherapy alone. Researchers at the University of Oklahoma Health Stephenson Cancer Center enrolled patients in the global trial.

Two University of Oklahoma College of Medicine faculty members, Mary Moon, Ph.D., and Priyabrata Mukherjee, Ph.D., were honored recently for their excellence in teaching and research. Moon received the 2026 Stanton L. Young Master Teacher Award, and Mukherjee received the Stanton L. Young Excellence in Research Award.

Recently published research from the University of Oklahoma and the University of Tulsa proposes a new model to explain why nightmares can persist over time in children and how therapy can be designed to break that cycle.

Ian F. Dunn, M.D., executive dean of the University of Oklahoma College of Medicine and chief physician executive for OU Health, the university’s health care partner, has been named to a one-year term with the Council of Deans Administrative Board with the Association of American Medical Colleges (AAMC).

A hormone that reverses obesity in mice appears to work by signaling to a brain region involved in metabolism and appetite regulation, the same area targeted by the popular GLP-1 drugs. The finding, from University of Oklahoma researchers, is published in Cell Reports.